OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium

Summary by AI BETAClose X

OKYO Pharma Limited announced its participation in the Piper Sandler Virtual Ophthalmology Symposium on July 9, 2026, where CEO Robert J. Dempsey and CMO Flavio Mantelli will present. The company is developing investigational therapies for neuropathic corneal pain and anterior segment eye diseases, having recently completed a Phase 2 trial for its drug urcosimod and planning to initiate a 150-patient Phase 2b/3 study for urcosimod in the first half of the year.

Disclaimer*

UK 100

Latest directors dealings